Location out of bounds
Radial
Radial

Newsroom

Resources for journalists

All Publications
von willebrand disease test

New Test for VWD Promises Better Diagnostics

Milwaukee – July 1, 2017

Technology allows for more precise measurement of von Willebrand factor activity

BY NANCY MANN JACKSON

The most common inherited bleeding disorder in the world, von Willebrand disease (VWD) has also been one of the most difficult to diagnose. But a new diagnostic test developed at BloodCenter of Wisconsin, in Milwaukee, is providing more precise, reliable results than traditional tests, allowing doctors to better diagnose VWD and provide treatment earlier for people with the disorder. “By utilizing the new test, practicing hematologists can be more confident that the results accurately reflect the clinical scenario of the patient,” says Kenneth Friedman, MD, medical director at BloodCenter of Wisconsin and associate medical director of BloodCenter’s Comprehensive Center for Bleeding Disorders. “Confidence in diagnosis more efficiently guides treatment decisions. When treatments are applied more rapidly, the quality of life and outcome for a patient with VWD, and potentially their family, improves.”

Read Full Article

Contact Information

Fay Spano

Director, Public Relations and Corporate Communications
Phone: (414) 937-6124 Email

Matthew Queen

Communications Specialist
Phone: (414) 937-6138 Email

Other Publications

This particular image depicts platelets spreading on an artificial fibrinogen-coated surface, demonstrating what would happen if someone cut themselves.

Blood Research Institute investigator wins journal cover photo contest

April 8, 2019

Congratulations to Hervé Falet, PhD, and his winning photo “Platelet Fireworks,” which appeared on the cover of medical journal Platelets.

Read More
Hervé Falet, PhD working with an assistant in his lab

Filling in the gaps to better understand platelet production

April 8, 2019

Hervé Falet, PhD, is an expert in platelet function and is investigating how they form in the bone marrow.

Read More
John Pulikkan, PhD

What's in a gene?

March 19, 2019

Dr. Pulikkan would like to develop drugs that are specially targeted to the mutated leukemia cells, so that the drugs would have no side effects.

Read More
ic-arrow-right
x

This website uses cookies to ensure you get the best experience on our website. Learn more